Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Common Stock | Purchase | $2.01K | +4K | +0.04% | $0.50 | 11.1M | Mar 16, 2023 | By Ault Lending, LLC | F1, F2 |
transaction | ALZN | Common Stock | Purchase | $2.15K | +5K | +0.05% | $0.43 | 11.1M | Mar 17, 2023 | By Ault Lending, LLC | F2 |
holding | ALZN | Common Stock | 2.5M | Mar 16, 2023 | Direct | ||||||
holding | ALZN | Common Stock | 365K | Mar 16, 2023 | By Ault Alpha LP | F3 | |||||
holding | ALZN | Common Stock | 14.9M | Mar 16, 2023 | By Ault Life Sciences, Inc. | F4 | |||||
holding | ALZN | Common Stock | 10M | Mar 16, 2023 | By Ault Life Sciences Fund, LLC | F5 |
Id | Content |
---|---|
F1 | The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5014. The range of purchase prices on the transaction date was $0.5014 to $0.5015 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |
F2 | Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AA"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |
F3 | Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP. |
F4 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |
F5 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. |